| Application no. and date | 14786429.2 (espacenet) (Federated) (European Patent Register), 20141007 | | Patent/reg. no. and date | DK/EP 3054927, 20190220 | | Publication date | 20160817 | | Priority no. and date | US 201361888419 P, 20131008 | | EP pub. no. and date |
EP 3054927 20160817 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P67748DK01 | | Inventor | MENON, Anil, 1717 Merriam Drive
Martinsville, NJ 08836, US,
PARIKH, Darshan, 1605 Vroom Drive
Bridgewater, NJ 08807, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 9/48 (2006.01) | | Title | FORMULERINGER AF (S)-3-(4-((4-MORPHOLINOMETHYL)BENZYLOXY)-1-OXOISOINDOLIN-2-YL)PIPERIDIN-2,6-DION | | Int. application no. | US2014059424 | | Int. publication no. | WO2015054199 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
